Exhibit 107
CALCULATION OF FILING FEE TABLES
Form S-3
(Form Type)
Marker Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| | Security Type | | Security Class Title | | Fee Calculation or Carry Forward Rule | | Amount Registered | | Proposed Maximum Offering Price per Unit | | Maximum Aggregate Offering Price | | Fee Rate | | Amount of Registration Fee | | Carry Forward Form Type | | Carry Forward File Number | | Carry Forward Initial Effective Date | | Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward |
|
Newly Registered Securities |
| | | | | | | | | | | | |
Fees to Be Paid | | Equity | | Common Stock, par value $0.001 per share | | 457(c) | | 10,062,500 (1)(2) | | $2.91 (3) | | $29,281,875 (3) | | $153.10 per $1,000,000 | | $4,483.06 | | | | | | | | — |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | Total Offering Amounts | | | | $29,281,875 | | $153.10 per $1,000,000 | | $4,483.06 | | | | | | | | |
| | | | | | | | | |
| | Total Fee Previously Paid | | | | | | | | — | | | | | | | | |
| | | | | | | | | |
| | Total Fee Offsets | | | | | | | | — | | | | | | | | |
| | | | | | | | | |
| | Net Fee Due | | | | | | | | $4,483.06 | | | | | | | | |
Table 2: Fee Offset Claims and Sources
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | |
| | Registrant or Filer Name | | Form or Filing Type | | File Number | | Initial Filing Date | | Filing Date | | Fee Offset Claimed | | Security Type Associated with Fee Offset Claimed | | Security Title Associated with Fee Offset Claimed | | Unsold Securities Associated with Fee Offset Claimed | | Unsold Aggregate Offering Amount Associated with Fee Offset Claimed | | Fee Paid with Fee Offset Source |
|
Rule 457(p) |
| | | | | | | | | | | |
Fee Offset Claims | | | | | | | | | | | | | | | | | | N/A | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
| (1) | The securities registered consists of (a) 1,783,805 shares of common stock, (b) 3,247,445 shares of common stock to be acquired upon the exercise of Pre-Funded Warrants, and (c) 5,031,250 shares of common stock to be acquired upon the exercise of Private Placement Warrants. | |
| (2) | The shares of common stock will be offered for resale by the selling stockholders pursuant to the prospectus contained herein. Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, this registration statement shall also cover any additional shares of the registrant’s securities that become issuable by reason of any share splits, share dividends or similar transactions. | |
| (3) | Estimated pursuant to Rules 457(c) under the Securities Act, solely for the purposes of calculating the registration fee and based on the average of the high and low prices of the Registrant’s common stock as reported on The Nasdaq Capital Market on January 8, 2025, which date is within five business days prior to the filing of this Registration Statement. | |